AA
ACHN

ALPS Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

ALPS Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-278,504
Closed -$1M – 875
2019
Q3 		$1M Sell
278,504
-11,856
-4% -$45.7K 0.01% 310
2019
Q2 		$778K Sell
290,360
-44,450
-13% -$131K 0.01% 388
2019
Q1 		$991K Buy
334,810
+14,460
+5% +$35.5K 0.01% 329
2018
Q4 		$509K Buy
320,350
+75,105
+31% +$212K ﹤0.01% 475
2018
Q3 		$903K Buy
245,245
+44,480
+22% +$133K 0.01% 429
2018
Q2 		$568K Buy
200,765
+15,797
+9% +$53.8K ﹤0.01% 509
2018
Q1 		$686K Buy
184,968
+32,205
+21% +$105K 0.01% 388
2017
Q4 		$440K Buy
152,763
+18,074
+13% +$65.7K ﹤0.01% 658
2017
Q3 		$605K Buy
134,689
+11,277
+9% +$50.1K ﹤0.01% 340
2017
Q2 		$566K Buy
123,412
+5,824
+5% +$23.4K ﹤0.01% 393
2017
Q1 		$495K Sell
117,588
-13,763
-10% -$57.1K ﹤0.01% 437
2016
Q4 		$542K Sell
131,351
-42,895
-25% -$228K ﹤0.01% 336
2016
Q3 		$1.41M Sell
174,246
-17,707
-9% -$151K 0.01% 205
2016
Q2 		$1.5M Buy
191,953
+38,285
+25% +$328K 0.01% 189
2016
Q1 		$1.19M Sell
153,668
-26,209
-15% -$192K 0.01% 178
2015
Q4 		$1.94M Sell
179,877
-4,131
-2% -$37.6K 0.02% 181
2015
Q3 		$12.7K Buy
184,008
+67,347
+58% +$549K 0.01% 202
2015
Q2 		$1.03M Buy
116,661
+60,811
+109% +$575K 0.01% 212
2015
Q1 		$551K Buy
+55,850
New +$697K ﹤0.01% 287

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ALPS Advisors's ACHN Position: Q4 2019 in Review

ALPS Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 278,504 shares — an estimated $1M sold.

ALPS Advisors first reported a position in ACHN in Q1 2015 and held it in 19 quarters. The position peaked at $1.94M in Q4 2015. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • ALPS Advisors reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • ALPS Advisors sold 278,504 Achillion Pharmaceuticals shares in Q4 2019, an estimated $1M.
  • ALPS Advisors first reported a position in Achillion Pharmaceuticals in Q1 2015 and held it in 19 quarters.
  • ALPS Advisors's Achillion Pharmaceuticals position peaked at $1.94M in Q4 2015.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on ALPS Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.